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Summary
 
Peripheral tolerance may be maintained by a population of regulatory/suppressor T cells that
prevent the activation of autoreactive T cells recognizing tissue-specific antigens. We have pre-
viously shown that CD4
 
1
 
CD25
 
1
 
 T cells represent a unique population of suppressor T cells
that can prevent both the initiation of organ-specific autoimmune disease after day 3 thymec-
tomy and the effector function of cloned autoantigen-specific CD4
 
1
 
 T cells. To analyze the
mechanism of action of these cells, we established an in vitro model system that mimics the
function of these cells in vivo. Purified CD4
 
1
 
CD25
 
1
 
 cells failed to proliferate after stimulation
with interleukin (IL)-2 alone or stimulation through the T cell receptor (TCR). When cocul-
tured with CD4
 
1
 
CD25
 
2
 
 cells, the CD4
 
1
 
CD25
 
1
 
 cells markedly suppressed proliferation by
specifically inhibiting the production of IL-2. The inhibition was not cytokine mediated, was
dependent on cell contact between the regulatory cells and the responders, and required activa-
tion of the suppressors via the TCR. Inhibition could be overcome by the addition to the cul-
tures of IL-2 or anti-CD28, suggesting that the CD4
 
1
 
CD25
 
1
 
 cells may function by blocking
the delivery of a costimulatory signal. Induction of CD25 expression on CD25
 
2
 
 T cells in vitro
or in vivo did not result in the generation of suppressor activity. Collectively, these data sup-
port the concept that the CD4
 
1
 
CD25
 
1
 
 T cells in normal mice may represent a distinct lineage
of “professional” suppressor cells.
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I
 
t is widely accepted that the development of autoim-
mune disease involves a breakdown in the mechanisms
that control self- versus nonself-discrimination. The pri-
mary mechanism that leads to tolerance to self-antigens is
thymic deletion of autoreactive T cells. However, some
autoreactive T cells may escape thymic deletion or recog-
nize antigens expressed only extrathymically. T cell anergy
(1) and T cell ignorance/indifference (2) have been pro-
posed as the primary mechanisms used to control these po-
tentially harmful populations. However, anergic or igno-
rant T cell populations have the potential to be activated
when their target self-antigens are released into the lym-
phoid system during the course of an infection or when
they are activated by cross-reactive epitopes present on in-
fectious agents (3). Thus, these “passive” mechanisms for
self-tolerance may not be sufficient to completely control
potentially pathogenic T cells. Over the past 10 years, evi-
dence has accumulated for an “active” mechanism of im-
mune suppression in which a distinct subset of cells sup-
presses the activation of autoreactive T cells that have
escaped the passive mechanisms of tolerance (4).
A number of organ-specific autoimmune diseases can be
induced in rodent strains that do not normally develop au-
toimmunity by procedures that interfere with normal T
cell maturation or by rendering the animals partially T cell
deficient (5). In general, a defined subset of T cells from
syngeneic healthy donors can prevent the development of
autoimmunity on transfer to lymphopenic recipients, indi-
cating that the normal immune system contains immuno-
regulatory T cells that can prevent the activation of autore-
active T cells (6). For example, Powrie et al. have shown
that colitis can be induced in immunodeficient SCID mice
by transfer of the CD45RB
 
high
 
 subset of CD4
 
1
 
 T cells from
normal mice, but not by the CD45RB
 
low
 
 population (7).
The CD45RB
 
low
 
 population, when transferred together
with the CD45RB
 
high
 
 population, completely inhibited de-
velopment of the disease. Evidence for the existence of
regulatory T cells has also been obtained in both the Bio-
Breeding rat and nonobese diabetic mouse strains that
spontaneously develop autoimmune diabetes (8, 9). Immu-
noregulatory T cells are also likely to be responsible for the
relative resistance of mice that express a transgenic TCR
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specific for a peptide from myelin basic protein to the de-
velopment of experimental allergic encephalomyelitis,
whereas mice that express the same TCR on a recombina-
tion activating gene (RAG)-deficient (
 
2/2
 
) background are
highly susceptible (10).
Although many of these studies have demonstrated that
the immunoregulatory T cells are present in the subpopula-
tion of CD4
 
1
 
 cells that express activation/memory mark-
ers, a more detailed phenotypic characterization of the sup-
pressor population is lacking. Studies using two different
model systems have suggested that a potent CD4
 
1
 
 immu-
noregulatory T cell population that can be defined by ex-
pression of the IL-2R 
 
a
 
 chain (CD25) is responsible for the
prevention of certain autoimmune diseases. In the first
model system (11, 12), genetically susceptible mice that
were thymectomized on day 3 of life (d3Tx)
 
1
 
 developed
organ-specific autoimmune disease involving one or more
organs. The disease process was mediated by CD4
 
1
 
 T cells;
however, CD4
 
1
 
 T cells from normal adult mice could in-
hibit the development of disease in the d3Tx animals if
they were transferred by day 14 of life. Furthermore, the
inhibitory activity was completely contained in the minor
(10%) subset of CD4
 
1
 
 T cells that coexpressed CD25 (13,
14). In the second model, when CD4
 
1
 
CD25
 
1
 
 T cells were
depleted from CD4
 
1
 
 T cells isolated from peripheral lym-
phoid tissues of normal adult mice and the remaining
CD4
 
1
 
CD25
 
2
 
 cells injected into 
 
nu/nu
 
 mice recipients, the
recipients developed a high incidence of organ-specific au-
toimmune disease (13, 15). Again, cotransfer of populations
enriched in CD4
 
1
 
CD25
 
1
 
 prevented the induction of dis-
ease by the CD4
 
1
 
CD25
 
2
 
 population. We have also re-
cently demonstrated that CD4
 
1
 
CD25
 
1
 
 T cells can inhibit
the capacity of a cloned line of autoantigen-specific effector
cells to transfer disease to 
 
nu/nu 
 
recipients (16). Thus, the
CD4
 
1
 
CD25
 
1
 
 population can inhibit both the induction
and effector function of autoreactive T cells.
Although the existence of immunoregulatory T cell
populations has been amply documented, the activity of
these suppressor populations has been measured in vivo in
model systems that require weeks to months of assessment
of disease activity. Therefore, it has proven difficult to de-
termine their mechanism of action, antigen specificity, or
cellular targets. In this report, we demonstrate that the pop-
ulation of CD4
 
1
 
CD25
 
1
 
 T cells present in the peripheral
lymphoid system of normal mice is a potent inhibitor of
polyclonal T cell activation in vitro. Suppression is medi-
ated by a cytokine-independent, cell contact–dependent
mechanism that requires activation of the suppressor cell
via the TCR. The CD4
 
1
 
CD25
 
1
 
 cells inhibit the induction
of IL-2 production in the responder CD4
 
1
 
CD25
 
2
 
 popula-
tion, and suppression can be overcome by the addition of
exogenous IL-2 or enhancement of endogenous IL-2 pro-
duction.
 
Materials and Methods
 
Mice.
 
Female BALB/c and C57BL/6 mice were obtained
from the National Cancer Institute (Frederick, MD). C57BL/10
mice were obtained from Taconic Farms (Germantown, NY).
DO.11.10-TCR transgenic SCID mice were bred in our own fa-
cilities (14). IL-4
 
2/2
 
 mice (BALB/c background) were originally
obtained from N. Noben-Trauth (NIAID, National Institutes of
Health) (17) and were bred in our facilities. IL-10
 
2/2
 
 mice were
originally obtained from R. Kuhn and W. Muller (University of
Koln, Koln, Germany) and backcrossed in our facilities onto the
C57BL/10 (N7) background. BALB/c mice were thymecto-
mized on day 3 of life and screened for the presence of antigastric
autoantibodies as previously described (18).
 
Media, Reagents, and Antibodies.
 
All cells were grown in RPMI
1640 (Biofluids, Rockville, MD) supplemented with 10% heat-
inactivated FCS, penicillin (100 U/ml), streptomycin (100 
 
m
 
g/ml),
2 mM 
 
l
 
-glutamine, 10 mM Hepes, 0.1 mM nonessential amino
acids, 1 mM sodium pyruvate (all from Biofluids), and 50 
 
m
 
M 2-ME
(Sigma Chemical Co., St. Louis, MO). PMA, ionomycin, and
Con A were purchased from Sigma Chemical Co. Biotin-conju-
gated anti-CD25 (7D4), FITC-conjugated streptavidin, PE-con-
jugated anti-CD45RB (16A), PE-conjugated anti-CD62L (Mel-14),
PE-conjugated anti-CD69, PE-conjugated anti-CD5, anti-CD28,
anti-CD40 (HM40-3), anti–B7-2 (GL1), anti–CTLA-4, anti–IL-2
(S4B6), anti–IL-4 (11B11), anti–IL-10 (JES5-2A5), or (SXC-1 and
SXC-2) and anti–IFN-
 
g
 
 (XMG1.2) were purchased from Phar-
Mingen (San Diego, CA). Anti–TGF-
 
b
 
 was purchased from
R&D Systems (Minneapolis, MN). PE-conjugated anti-CD4 was
purchased from Becton Dickinson (Mountain View, CA). Anti-
CD3 (2C11) was purified from ascites and used at 1–3 
 
m
 
g/ml or
purchased from PharMingen and used at 0.5 
 
m
 
g/ml. Human rIL-2
was purchased from Peprotech (Rocky Hill, NJ). Flow cytometry
analysis was analyzed using Cell Quest
 
Ò
 
 software (Becton Dickinson).
 
Cell Purification.
 
LNs (axillary, inguinal, superficial cervical,
mandibular, and mesenteric) were harvested from 8–10-wk-old
female mice. They were mashed through a wire mesh into
HBSS/5% FCS to prepare single cell suspensions. LN prepara-
tions were then enriched for T cells on T cell columns (R&D
Systems). To purify CD4
 
1
 
CD25
 
1
 
 cells, the enriched T cells were
incubated with biotin-conjugated anti-CD25 (15 
 
m
 
g/10
 
8
 
 cells) in
PBS/2% FCS for 15 min at 4
 
8
 
C, washed, incubated with FITC-
conjugated streptavidin (15 
 
m
 
g/10
 
8
 
 cells) in PBS/2% FCS for 15
min at 4
 
8
 
C, and washed. The cells were then incubated with anti-
FITC microbeads (Miltenyi Biotec, Inc., Auburn, CA) for 15
min at 4
 
8
 
C and magnetic separation was performed with a VS
 
1
 
positive selection column according to the suggested protocol
(Miltenyi). The retained cells were eluted from the column as pu-
rified CD4
 
1
 
CD25
 
1
 
 cells. The flow-through was then passed over
CD4
 
1
 
 subset columns (R&D Systems) to obtain CD4
 
1
 
CD25
 
2
 
cells. The purity of CD4
 
1
 
CD25
 
1
 
 cells typically ranged from 88
to 95%. For some experiments, CD4
 
1
 
CD25
 
1
 
 cells were purified
from LN cells by flow cytometry using PE-conjugated anti-CD4
and FITC-conjugated anti-CD25 on a FACStar
 
Ò
 
 Cell Sorter
(Becton Dickinson); the resultant purity was 99.5%. T cell–
depleted spleen suspensions were prepared by first lysing the
erythrocytes with ACK lysis buffer, followed by treatment with
anti–Thy 1.2 culture supernatants (HO-13.4) and rabbit comple-
ment for 45 min at 37
 
8
 
C.
 
Proliferation Assays.
 
CD4
 
1
 
CD25
 
2
 
 cells were cultured in 96-well
plates (0.2 ml) with T cell–depleted spleen cells as accessory cells
(ACs) (3,000 R irradiated), 0.5 
 
m
 
g/ml anti-CD3 (or coated with
10 
 
m
 
g/ml anti-CD3 for plate-bound), and the indicated numbers
 
1
 
Abbreviations used in this paper:
 
 AC, accessory cell; d3Tx, thymectomized
on day 3 of life; FasL, Fas ligand; RT, reverse transcriptase. 
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of CD4
 
1
 
CD25
 
1
 
 cells for 72 h at 37
 
8
 
C/7% CO
 
2. 
 
Cultures were
pulsed with [
 
3
 
H]TdR for the last 6 h of culture. Transwell
 
Ô
 
 exper-
iments  were carried out in 24-well plates (0.8 ml) with
CD4
 
1
 
CD25
 
2
 
 cells, AC, and 0.5 
 
m
 
g/ml anti-CD3 in the presence
or absence of CD4
 
1
 
CD25
 
1
 
 cells in the Transwell
 
Ô
 
 (Corning
Costar, Cambridge, MA).
 
Reverse Transcriptase PCR Reactions.
 
CD4
 
1
 
CD25
 
2
 
 cells or CD4
 
1
 
CD25
 
1
 
 cells were purified and were left unstimulated or stimu-
lated for 15 h with T cell–depleted spleen and 0.5 
 
m
 
g/ml anti-
CD3. RNA was purified with RNAzol B (Tel-test, Friends-
wood, TX) and cDNA was reverse transcribed from 3 
 
m
 
g of
RNA using Superscript II (GIBCO BRL, Gaithersburg, MD).
PCR reactions were carried out with Ready To Go
 
Ò
 
 PCR beads
(Pharmacia Biotech AB, Piscataway, NJ) using 1 
 
m
 
l of cDNA re-
action. 
 
b
 
-actin, IL-2, IL-4, IL-10, IFN-
 
g
 
, and TNF-
 
a
 
 primers
were purchased from Clontech (Palo Alto, CA). Fas ligand (FasL)
upper: 5
 
9
 
-CTGGTGGCTCTGGTTGGAAT-3
 
9 and lower: 59-
GTTTAGGGGCTGGTTGTTGC-39 were synthesized by Bio-
Synthesis (Lewisville, TX).
Cytokine ELISA and Northern Blot Analysis. Cultures for North-
ern blot analyses and ELISAs were carried out in 24-well plates
(0.8 ml) with 5 3 105 CD41CD252 cells/well, 5 3 105 AC, and
0.5 mg/ml anti-CD3 in the presence or absence of 2.5 3 105
CD41CD251 cells. For ELISAs, supernatants were taken at the
indicated times and IL-2 was quantified as previously described
(19) using JES6-1A12 as the capture antibody and JES6-5H4 as
the detection antibody. The lower limit of detection was 78 pg/
ml. For Northern blot analysis, RNA was purified after 16 h, us-
ing RNAzol B (Tel-test). Northern blots were performed with 5
mg of RNA using the IL-2 PCR fragment or b-actin PCR frag-
ment (using Clontech primers) as a probe. The PCR fragment
was labeled with [32P]dCTP using an oligolabeling kit (Pharmacia
Biotech AB). The final washing conditions were 0.13 SSC, 0.1%
SDS at 658C.
Results
Phenotypic and Functional Characterization of CD41CD251
Cells. The CD41CD251 population typically represented
5–8% of the total LN population or 10–15% of CD41 cells
(Fig. 1 A, left). This population could be isolated easily to
levels of 90–95% purity (Fig. 1 A, right) with the magnetic
anti-FITC microbead procedure (see Materials and Meth-
ods), and the labeled cells could then be analyzed directly
on the FACSÒ or placed into culture. When compared
with CD41CD252 T cells, the CD41CD251 cells were
similar in their pattern of expression of CD5, had a slightly
higher proportion of CD62Llow cells, and had a higher pro-
portion of CD691 cells (Fig. 1 B). They had an unusual
pattern of expression of CD45RB, and were composed
primarily of cells that expressed intermediate and low lev-
els. Thus, although modestly enriched in cells that express
activation/memory cell markers, the CD41CD251 popu-
lation contained a significant proportion of cells with a na-
ive/resting phenotype. All of the CD41CD251 cells ex-
pressed TCR-a/b at a level similar to that of the CD41
CD252 population; the percentage of cells in both popula-
tions that expressed a given Vb was also identical (data not
shown).
Although their constitutive expression of CD25 raised
the possibility that the CD41CD251 population might be
hyperresponsive to stimulation with IL-2 and/or via the
TCR, they were completely unresponsive to stimulation with
high concentrations of IL-2, soluble anti-CD3, plate-bound
anti-CD3, and Con A in the presence of T cell–depleted
spleen cells as AC (Fig. 1 C). Moreover, they were also un-
responsive to stimulation with anti-CD3 and optimal con-
centrations of anti-CD28. However, the addition of IL-2
did restore responsiveness to soluble anti-CD3 to levels
similar to those observed with the CD41CD252 population.
In addition, the CD41CD251 responded normally when
stimulated with the TCR-independent stimuli, phorbol es-
ter and calcium ionophore or phorbol ester and IL-2.
CD41CD251 Cells Suppress the Responses of CD41
CD252 T Cells. When the CD41CD251 population was
Figure 1. Characterization of CD41CD251 cells. (A) Total lymph
node cells (left) or purified CD41CD251 cells (right) from BALB/c mice
were stained with PE-conjugated anti-CD4 and biotin-conjugated anti-
CD25 followed by FITC-conjugated streptavidin. (B) Purified CD41
CD252 cells or purified CD41CD251 cells were double stained for CD25
and the indicated surface molecules. (C) Proliferative responses of CD41
CD251 cells. Cells (5 3 104) were incubated with the indicated agents
(10 ng/ml PMA, 1 mM ionomycin, 3 ng/ml IL-2, 3.0 mg/ml soluble
anti-CD3, 3.0 mg/ml Con A, 10 mg/ml anti-CD28, or wells coated with
10 mg/ml anti-CD3) in the presence of AC (5 3 104). Results are ex-
pressed as the mean of triplicate cultures.290 CD41CD251 Suppressor T Cells
cocultured with CD41CD252 cells, marked suppression of
the response to stimulation with soluble, but not plate-
bound, anti-CD3 was observed (Fig. 2 A). Moreover, re-
sponses to Con A in the presence of AC were similarly in-
hibited and the suppression was not restricted by the MHC
as CD41CD251 T cells from BALB/c mice suppressed the
response of CD41CD252 T cells from C57BL/6 mice (data
not shown). In multiple experiments of this type, signifi-
cant suppression (.70%) of the response to soluble anti-
CD3 was observed at a final ratio of suppressors/responders
of 1:4 and complete suppression was seen at ratios of 1:2.
Suppression was not overcome by increasing the concen-
tration of soluble anti-CD3 (data not shown). Most impor-
tantly, suppression required activation of the CD41CD251
population, as the CD251 cells were unable to suppress the
antigen-specific responses of CD41CD252 T cells from
mice that expressed an antiovalbumin transgenic TCR, but
could readily suppress the response of the same cells to anti-
CD3 (Fig. 2 B).
The Suppressive Effects of CD41CD251 Cells Are Cytokine
Independent and Cell Contact Dependent. It seemed likely that
one mechanism by which the CD41CD251 T cells could
mediate suppression was by the secretion of suppressor cy-
tokines. Supernatants derived from anti-CD3–stimulated
CD41CD251 contained low levels of IL-10, but contained
no detectable levels of IL-2, IL-4, or IFN-g (data not shown).
When the CD41CD251 cells were examined for cytokine
gene expression by reverse transcriptase (RT)-PCR, IL-2
mRNA was not detected, but it was readily detectable
when CD41CD252 cells were stimulated with anti-CD3
(Fig. 3). This result is consistent with the failure of the
CD41CD251 T cells to proliferate when stimulated with
anti-CD3. Activated CD41CD251 cells did not express
significant amounts of IL-4 mRNA, but the levels of IL-10
mRNA were increased in both unstimulated and anti-
CD3–stimulated CD41CD251 populations when com-
pared with CD41CD252 cells. FasL message was lower in
resting CD41CD251 cells and was not induced by stimula-
tion, whereas TNF-a was upregulated comparably in both
CD251 and CD252 populations. These results are in con-
trast to the results of Asano et al. (13), in which unstimu-
lated CD41CD251 cells expressed IL-2, IL-4, and TGF-b,
as well as IL-10.
The IL-10 ELISA and RT-PCR data raised the possibil-
ity that IL-10 might mediate the suppressive activity of the
CD41CD251 cells. However, when CD41CD251 were
separated from CD41CD252 cells by culture in a Trans-
wellÔ, suppression was not observed (Fig. 4 A). Further-
more, the addition of neutralizing antibodies to IL-10 as
well as other known suppressive cytokines alone or in com-
bination also failed to abrogate suppression (Fig. 4 B). As it
remained possible that an unknown suppressor cytokine was
operative in this model, supernatants were collected from
stimulated CD41CD251 cells or stimulated CD41CD252
cells coincubated with CD41CD251 cells and tested for
their capacity to suppress the responses of freshly explanted
CD41CD252 cells (Fig. 4 C); however, no suppression
was seen. Lastly, to definitively rule out the involvement of
IL-4 or IL-10 in this system, CD41CD251 T cells were
purified from mice genetically deficient in these cytokines.
CD41CD251 cells from both of the knockout mice were
comparable to controls in their ability to suppress (Fig. 5).
Collectively, these studies demonstrate that CD41CD251
cells do not mediate their suppressive effects by secretion of
a soluble suppressor factor.
CD41CD251 Cells Suppress IL-2 Production by CD41
CD252 Cells. As an initial approach to an analysis of the
cell surface molecules that might be involved in mediating
cell contact–dependent suppression in this in vitro model,
we added various antibodies to cell surface antigens that
could be targets of the CD41CD251 cells. We focused our
efforts on the two major pathways involved in the interac-
Figure 2. CD41CD251 cells suppress the proliferation of CD41 cells.
(A) CD41CD252 cells (5 3 104) were incubated with plate bound anti-
CD3 (triangles) or with 1.0 mg/ml soluble anti-CD3 (squares) in the pres-
ence of AC (5 3 104) and the indicated number of CD41CD251 cells.
(B) CD41CD251 cells do not suppress antigen-specific CD41 cells from
TCR transgenic mice. CD41CD252 cells (5 3 104) were purified from
DO.11.10 SCID mice on a BALB/c background and stimulated with 0.5
mM ovalbumin peptide (amino acid 323–339; triangles) or 0.5 mg/ml anti-
CD3 (squares) in the presence of AC (5 3 104) and the indicated number
of CD41CD251 cells. Results are expressed as the mean of triplicate cul-
tures.
Figure 3. PCR analysis of
CD41CD251 cells. RNA was
purified from 6–8 3 106
CD41CD252 or CD41CD251
cells either unstimulated or stim-
ulated with an equivalent num-
ber of AC and 0.5 mg/ml anti-
CD3 for 15 h. RNA was reverse
transcribed and primers for the
indicated genes were used to am-
plify the cDNA. The number of
cycles for each primer set are as
follows: b-actin, 20 cycles; IL-2,
25 cycles; IL-4, IL-10, TNF-a,
and FasL, 30 cycles.291 Thornton and Shevach
tion between CD41 cells and AC, namely CD28-CTLA-
4/B71/2 and the CD40/CD40L pathways. As previously
reported (20), addition of either anti–CTLA-4 or anti-
CD40 had modest enhancing effects on the responses of
the CD41CD252 cells, but had no effects on the suppres-
sion of the responses by the CD41CD251 cells (Fig. 6).
Anti–B7-2 completely inhibited stimulation of the CD41
CD252 population, as B7-2 is the major costimulatory mol-
ecule expressed by resting T cell–depleted spleen cells that
were used as AC. Most importantly, the addition of anti-
CD28 or exogenous IL-2 not only markedly enhanced the
responses of the CD41CD252 cells, but almost completely
abrogated the suppressive effects due to CD41CD251 cells.
The neutralization of suppression by the addition of IL-2
or anti-CD28 to the cocultures of CD41CD251 and
CD41CD252 populations, as well as the ability of exoge-
nous IL-2 to overcome the nonresponsiveness of the
CD41CD251 cells when cultured alone (Fig. 1), raised the
possibility that the CD251 population was exerting its in-
hibitory effects by binding IL-2 and functioning as an “IL-2
sink”. We initially examined IL-2 production in anti-
CD3–stimulated cultures of CD41CD252, CD41CD251,
and the mixture of the two populations by ELISA. IL-2
was readily detectable in the supernatants of CD41CD252
cells cultured alone, undetectable in the supernatants of CD41
CD252 cells, and markedly reduced in the supernatants of
the coculture (Fig. 7 A). This result is consistent with the
possibility that the CD41CD251 population was blocking
the production of IL-2 by the CD41CD251 cells, but it
did not rule out the possibility that the CD41CD251 cells
inhibited proliferation by sequestering IL-2. Therefore, we
directly examined the induction of IL-2 mRNA by North-
ern blot analysis. IL-2 mRNA was readily detected when
the CD41CD252 cells were cultured alone, but was unde-
tectable when the CD41CD252 and CD41CD251 were
cocultured (Fig. 7 B). Although the level of b-actin mRNA
was slightly lower in the cocultures, longer exposure of this
blot did not reveal IL-2 mRNA. In other experiments, a
faint band for IL-2 mRNA could sometimes be seen. In
any case, these results strongly support the view that the
CD41CD251 population exerts its inhibitory effects by block-
ing the induction of IL-2 production by the CD41CD252
cells at the level of RNA transcription.
The Induction of CD25 on CD252 Cells Does Not Lead to
the Generation of Suppressor Cells.  We and others have shown
that the CD41CD251 population is solely responsible for
Figure 4. A soluble factor does not mediate CD41CD251 induced suppression. (A) CD41CD252 cells (5 3 105) were cultured in 24-well plates in
the presence of 3.0 mg/ml soluble anti-CD3 and AC (5 3 105). The indicated number of CD41CD251 cells was added directly to the culture (squares) or
to the transwell in the absence (triangles) or presence (circles) of AC (5 3 105). (B) CD41CD252 cells (5 3 104) were cultured with AC (5 3 104), 0.5 mg/
ml anti-CD3, and 10 mg/ml of the indicated antibodies in the absence (white bars) or presence (black bars) of CD41 CD251 cells (2.5 3 104). (C) Super-
natants were collected after a 48-h stimulation with soluble anti-CD3 and AC (5 3 104) from CD41CD252 cells alone (5 3 104), CD41CD251 cells
alone (5 3 104), or CD41CD252 (5 3 104) cells coincubated with CD41CD251 cells (2.5 3 104). Supernatants (0.1 ml) were then added to CD41 cells
(5 3 104) stimulated with anti-CD3 and AC (5 3 104). Results are expressed as the mean of triplicate cultures.
Figure 5. CD41CD251 cells from IL-102/2 and IL-42/2 mice suppress
proliferation. CD41CD251 cells were purified from (A) IL-42/2 and
BALB/c control mice or (B) IL-102/2 and C57BL/10 mice, and the indi-
cated numbers were coincubated with CD41CD252 cells (5 3 104) from
control mice stimulated with 0.5 mg/ml anti-CD3 and AC (5 3 104).
Results are expressed as the mean of triplicate cultures.
Figure 6. Abrogation of sup-
pression by IL-2 or anti-CD28.
CD41 CD252 cells (5 3 104)
were cultured in the presence or
absence of CD41CD251 cells
(2.5  3  104) and 10 mg/ml of the
indicated antibodies or 3 ng/ml
IL-2. Results are expressed as the
mean of triplicate cultures.292 CD41CD251 Suppressor T Cells
inhibition of the induction of autoimmunity after 3dTx
(13, 14). In addition, we have also demonstrated that the
induction of CD25 expression on CD252 T cells derived
from mice that express a transgenic TCR on a SCID back-
ground was not sufficient to suppress the induction of au-
toimmune disease after 3dTx in vivo. This result raised the
possibility that the CD41CD251 cells present in normal
mice represent a unique cell population. To extend these
studies to our in vitro model, we purified CD41CD252
from normal mice, cultured them for 24 h in the presence
of Con A to induce CD25 expression, and then mixed them
with freshly isolated CD41CD252 cells. Although .80%
of the Con A–stimulated CD252 cells expressed CD25
(data not shown), no suppression of the proliferative re-
sponses of the CD41CD252 cells was observed (Fig. 8 A).
This result demonstrates that the mere expression of CD25
is insufficient to mediate suppression.
It has been postulated that the induction of autoimmu-
nity after 3dTx is secondary to a deficiency of the CD41
CD251 population that develops later during ontogeny (13).
Paradoxically, a greater percentage (25–30 versus 10%) of
CD41 T cells in 3dTx mice express CD25 compared with
normal mice (18). To rule out the possibility that the in
vivo induction of CD25 would render cells suppressive,
CD41CD251 cells were purified from 3dTx mice between
4 and 6 mo of age and added to cultures of CD41CD252
cells from normal BALB/c mice. No suppression was ob-
served in these cocultures (Fig. 8 B). These results again
support the view that the CD41CD251 cells present in
normal mice are a unique suppressor population and that
the CD41CD251 in the 3dTx mice are autoimmune effec-
tor cells.
Discussion
The role of immunoregulatory or suppressor T cells has
been well documented in the immunologic literature over
the past 25 years. However, a great deal of controversy re-
mains as to their lineage, antigen specificity, and mecha-
nism of action. The concept of antigen-specific suppressor
factors that acted in a complex cascade has not been vali-
dated by biochemical and molecular studies (21). Many of
the older in vivo studies on the activity of suppressor cells
have been reinterpreted as being secondary to alterations in
the Th1–Th2 balance that was induced by different modes
of antigen delivery. Most recent data on the importance of
suppressor cells has been derived from their involvement in
mediating transplantation tolerance and in preventing the
induction of autoimmune disease. The induction of au-
toimmune disease after 3dTx has been considered for many
years to be secondary to a deficiency of T suppressor cells
that normally develop after day 3 of life. The suppressor
cells in this model belong to the minor subpopulation of
CD41 T cells that coexpress CD25 and are capable of sup-
pressing the induction of autoimmunity after 3dTX, the
induction of autoimmunity induced by transfer of CD41
CD252 T cells to nu/nu recipients, and the capacity of acti-
vated autoantigen-specific T cell clones to induce disease in
nu/nu recipients.
The goal of our study was to develop an in vitro model
system in which the function of these potent CD41CD251
Figure 7. CD41CD251 cells suppress IL-2 production. (A) CD41
CD252 cells (5 3 104), AC (5 3 104), and 0.5 mg/ml anti-CD3 were cul-
tured in the presence or absence of CD41CD251 cells (2.5 3 104), super-
natants were taken at the indicated times and IL-2 was quantified. Each
sample was tested in triplicate. (B) RNA was purified from CD41 cells
stimulated in the presence or absence of CD41CD251 cells after 16 h us-
ing RNAzol B (Tel-test). RNA was separated by gel electrophoresis,
transferred to nitrocellulose and probed for IL-2 message (top) or b-actin
message (bottom) by using an IL-2 PCR fragment or a b-actin PCR prod-
uct as a probe.
Figure 8. (A) CD41CD251 cells were purified from BALB/c mice
while CD41CD252 cells were obtained by cell sorting and were cultured
with AC and Con A for 24 h and were then used as induced CD41CD251
cells. Induced or control CD41CD251 cells were then coincubated with
0.5 mg/ml anti-CD3 and AC. (B) CD41CD251 cells were purified from
3dTx mice or BALB/c control mice and coincubated with CD41CD252
cells from control mice stimulated with 0.5 mg/ml anti-CD3 and AC.
Results are expressed as the mean of triplicate cultures.293 Thornton and Shevach
T cells could be analyzed. We found that the CD41CD251
cells were themselves completely nonresponsive to stimula-
tion by TCR-derived signals in the presence or absence of
costimulation. More importantly, they could adoptively
suppress the responses of CD41CD252 cells in coculture
studies. Although suppression in many model systems in
vivo and in vitro is mediated by the secretion of one of the
suppressor cytokines (IL-4, IL-10, or TGF-b), the mecha-
nism of suppression by CD41CD251 cells appeared to be
mediated by a contact-dependent mechanism. No suppres-
sion was seen when the suppressors were separated from
the responders by a semipermeable membrane, and super-
natants from stimulated CD41CD251 cells could not trans-
fer suppression. Neutralizing antisuppressor cytokine mAbs
alone or in combination also failed to abrogate suppression.
Finally, to rule out the involvement of the newly described
(22) T regulatory 1 population that exerts bystander sup-
pression by the secretion of IL-10, we demonstrated that
CD41CD251 cells from both IL-42/2 and IL-102/2 donors
were as effective as T cells from wild-type mice in mediat-
ing suppression in vitro. We have also shown that these
same CD41CD251 cells from cytokine-deficient mice are
capable of mediating suppression of autoimmune disease in
vivo when they are transferred to d3Tx mice (McHugh,
R., A.M. Thornton, and E.M. Shevach, unpublished ob-
servations). Although we were unable to neutralize sup-
pression in vitro with anti–TGF-b, it still remains possible
that TGF-b may play some role in the action of these cells
in vivo, as TGF-b2/2 mice develop spontaneous inflamma-
tory disease of a variety of organs and have an increase in
Th1 inflammatory cytokines (23). The potential relation-
ship of the CD41CD251 population to the CD45RBlow
cells whose ability to protect animals from inflammatory
bowel disease could be reversed by anti–TGF-b (24) and
with TGF-b–producing suppressor populations (the so-
called Th3 cells) induced by oral delivery of antigen (25,
26) remains to be determined.
The requirement for cell contact to observe suppression
raised the possibility that the CD41CD251 population
might be mediating suppression by actually killing the re-
sponder T cell population by the Fas/FasL pathway. How-
ever, no evidence for cell death was observed in the cocul-
tures and identical numbers of viable cells were recovered
in the presence or absence of the CD41CD251 cells after
24 h of culture (data not shown). Furthermore, we could
not detect mRNA by RT-PCR for the FasL after stimula-
tion of the CD41CD251 cells with anti-CD3, whereas it
was readily induced in the CD41CD252 population. An-
other potentially trivial mechanism by which the CD251
population might be mediating inhibition was by passively
absorbing IL-2 produced by the responder cells. We defin-
itively ruled out this possibility by demonstrating that the
suppressor cells almost completely inhibited IL-2 gene
transcription and hence IL-2 production in the responder
T cell population. Inhibition of IL-2 gene transcription has
also been observed with suppressor T cell populations iso-
lated from animals that have been recently subjected to to-
tal lymphoid irradiation (TLI; reference 27). No informa-
tion is available on the phenotype of the suppressor cells in
that model, but spleen cells from TLI-treated animals con-
tain increased numbers of CD42CD82CD3low cells. Al-
though the binding of IL-2 by the CD41CD251 cells ap-
peared to play no role in suppression, it is still possible that
the expression of CD25 may be related to the functional
capacity of these cells to inhibit the development of autoim-
mune effector cells as IL-2 2/2, IL-2R b-chain (CD122)2/2,
and CD252/2 mice develop multiple manifestations of in-
flammatory autoimmune diseases (28–31). These studies
suggest that IL-2 itself may either directly or indirectly play
an important role in the development and/or function of
this unique population of CD251 suppressor cells.
There are a number of unique aspects of suppression in
this in vitro model which may offer some insight into the
physiological function of the CD41CD251 cells in vivo.
First, suppression in vitro required that the suppressor pop-
ulation be exposed and presumably activated via the TCR
since the antigen-specific response of naive T cells from
TCR transgenic mice was not suppressed by the CD41
CD251 cells, whereas the responses of the same cell mix-
ture to anti-CD3 stimulation were completely suppressed.
Second, the responses to soluble anti-CD3 in the presence
of normal T cell–depleted spleen cells were easily sup-
pressed, whereas the responses to plate-bound anti-CD3
were unaffected. This result may be secondary to a qualita-
tively distinct activating signal by plate-bound mAb, but is
also consistent with the possibility that the target of the
suppressor population is actually the AC rather than the re-
sponding T cell. Lastly, suppression could be overcome in
the coculture studies by the addition of IL-2 or by enhanc-
ing endogenous IL-2 production by the addition of anti-
CD28 to the cultures. It thus appears that the induction of
the IL-2R on the responder population is not blocked by
the addition of the suppressor population, and we have
confirmed this by FACSÒ analysis (data not shown). Again,
this observation is consistent with the possibility that the
AC is the target of the suppressor cell; however, as of yet
we have not been able to demonstrate that the suppressor
cells interfered with the delivery of either positive or nega-
tive costimulatory signals. The addition of anti–CTLA-4
did not reverse suppression (Fig. 6), and CD41CD251 cells
from either CD282/2 or CD40L2/2 mice were fully capa-
ble of inhibiting anti-CD3 stimulation in vitro (data not
shown).
It should also be noted that the nonresponsiveness of the
purified CD41CD251 to stimulation with anti-CD3 could
be overcome by the addition of exogenous IL-2. It is possi-
ble that the anergic state of the CD41CD251 population
was broken by the addition of IL-2. Alternatively, as the
CD41CD251 population is heterogeneous in expression of
the membrane markers we have studied (Fig. 1 B), the re-
sponse seen in the presence of IL-2 may be secondary to
CD251 conventional memory T cells that “contaminate”
the suppressor cell population. Surprisingly, the addition of
anti-CD28 had no effect on the proliferative responses of294 CD41CD251 Suppressor T Cells
the CD41CD251 population, while abrogating the sup-
pression in the cocultures of the CD251 and CD252 cells.
In the latter case, the anti-CD28 may directly stimulate the
CD252 cells to produce IL-2, whereas in the former the
vast excess of suppressors may still be capable of inhibiting
anti-CD28–induced IL-2 production by the few conven-
tional memory cells present in the CD251 pool.
Sakaguchi et al. (32) have proposed that any CD251 cell,
rather than a distinct, functional CD41CD251 subset, may
mediate suppression. We have previously shown that the
induction of CD25 on a homogeneous population of
CD252 T cells derived from the TCR-transgenic SCID
mouse was insufficient to prevent the induction of post-
3dTX autoimmunity in vivo. Similarly, suppression of pro-
liferation was not seen when CD251 cells, generated by in
vitro mitogen stimulation of CD252 cells, were added to
fresh CD252 populations. Not surprisingly, CD251 T cells
derived from 3dTx animals were also unable to mediate
suppression. In both of these latter situations, enhancement
of proliferation was usually observed. We have been unable
to detect any differences in the level of expression of the
a/b-TCR between CD251 and CD252 cells; the pattern
of Vb usage was also identical in both populations. One ca-
veat in the interpretation of these results is the potential
heterogeneity of the CD251 population. Studies are now in
progress to determine whether the suppressive activity of the
CD251 cells can be localized to a smaller subpopulation
(e.g., CD691, CD62Llow, CD45RBlow or int). It is possible
that restrictive TCR usage might be observed if suppressor
activity can be localized to a more defined subpopulation of
CD251 cells. Our data support the concept that the
CD41CD251 may represent a distinct lineage of profes-
sional suppressor cells.
One of the major drawbacks of this in vitro model is that
as yet we have been unable to separate the requirements for
activation of the suppressor populations from those of the
responder populations and this has hindered our further
analysis of the antigen specificity (if any) of the suppressor
cells and their cellular targets. Several studies (33, 34) have
presented evidence that the CD41CD251 population in
the 3dTx model recognizes the same set of autoantigens as
the autoantigen-specific effector pool, but these findings
have not been confirmed (35). No data are available as to the
antigen-specificity of the regulatory cells in the models where
lymphopenic animals are reconstituted with CD45RBlow
cells although it has been proposed that the T cells that me-
diate dominant tolerance recognize the autoantigen or pep-
tides derived from it (36) and that both the effector and
suppressor repertoires are generated in the thymus. No
studies have suggested that receptor-based immunoregula-
tion (37, 38) is operative in these model systems. Although
our in vitro studies on polyclonal activation do not address
the issue of the antigen-specificity of suppressor cells, they
are most consistent with a model in which the suppressor
and effector populations compete at the AC surface for an-
tigen and/or costimulatory signals. To a certain extent, our
results resemble the observations of Lombardi et al. (39),
who have shown that one mechanism by which anergic
antigen-specific T cell clones inhibit proliferative responses
of normal T cell clones in cocultures is by competition for
antigen or costimulatory signals generated at the surface of
the AC. Cobbold et al. (40) have also proposed that the
suppressor populations induced by nondepleting anti-CD4
mAbs in a model of infectious transplantation tolerance are
alloantigen-specific cells that are incapable of differentiating
into effectors, but function by inhibiting the delivery of an-
tigen/costimulatory signals to the effector population. One
possibility is that the CD41CD251 cells are themselves spe-
cific for ubiquitously expressed autoantigens. Such cells
would have escaped negative selection in the thymus be-
cause they would have downregulated their TCR signaling
properties and their capacity to differentiate into effector
cells. However, they could compete for costimulatory sig-
nals with low affinity autoreactive precursor cells on the
surface of the same AC. The in vitro model system de-
scribed in this report should facilitate identification of the
antigen specificity and the mechanism of suppression of
these potent regulatory cells.
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